Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer-Reference-Cited by-同舟云学术

Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer

Published:2002-09-16 Issue:10 Volume:8 Page:1136-1144
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Viglietto Giuseppe,Motti Maria Letizia,Bruni Paola,Melillo Rosa Marina,D'Alessio Amelia,Califano Daniela,Vinci Floriana,Chiappetta Gennaro,Tsichlis Philip,Bellacosa Alfonso,Fusco Alfredo,Santoro Massimo

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm762.pdf

Reference44 articles.

1. Morgan, D.O. Principles of Cdk regulation. Nature 374, 131–134 (1995).

2. Sherr, C.J. & Roberts, J.M. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501–1512 (1999).

3. Hanahan, D. & Weinberg, R.A. The hallmarks of cancer. Cell 100, 57–70 (2000).

4. Sherr, C.J. Cancer cell cycles. Science 274, 1672–1677 (1996).

5. Hunter, T. & Pines, J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79, 573–582 (1994).

Cited by 598 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C-terminally phosphorylated p27 activates self-renewal driver genes to program cancer stem cell expansion, mammary hyperplasia and cancer;Nature Communications;2024-06-17

2. CIP/KIP and INK4 families as hostages of oncogenic signaling;Cell Division;2024-04-01

3. CDKN1B(p27^kip1) enhances drug tolerant persister CTCs by restricting polyploidy following mitotic inhibitors;2024-02-22

4. The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant HER2-positive breast cancer;Theranostics;2024

5. Schistosoma mansoni–Induced Oxidative Stress Triggers Hepatocellular Proliferation;Cellular and Molecular Gastroenterology and Hepatology;2024